AI-Powered Precision
for Every Trial Decision
Empowering Every Decision in Drug Development
Despite investing $2.6 billion and 6–8 years per asset, nearly 90% of clinical programs stall.
Abyx turns your multimodal data into a phase-aware risk engine that anticipates safety and efficacy issues, optimizes study design and dosing from Day 0, customizes mitigation and monitoring, secures collaboration and delivers regulator-ready recommendations instantly.
BOOK A DEMOJoin Our Journey
Abyx is pioneering a new era in biologic safety through AI-driven insights.
We invite visionary investors and strategic partners to partner with us in revolutionizing clinical trials and transforming patient care.
Together, we’ll turn breakthrough science into real-world impact—accelerating safer drugs to market and reshaping the future of medicine.
Get in Touch